Physician profile
Muneeb Ilyas
NPI 1659876308
$1,316.76
in general payments reported to CMS, 2019-2025
17 companies · $210 in 2025
The $210 reported for 2025 was less than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $168 · 2022: $106 · 2023: $460 · 2024: $374 · 2025: $210.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,043.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,043.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ucb, INC. | $259.59 | 2023-2025 | Bimzelx, Cimzia |
| Abbvie INC. | $197.90 | 2023-2024 | |
| Allergan, INC. | $149.63 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $124.99 | 2023 | Sotyktu |
| Epi Health, LLC | $80.00 | 2022 | |
| Janssen Biotech, INC. | $77.65 | 2024-2025 | Tremfya, Simponi, Simponi Aria |
| Leo Pharma INC. | $74.40 | 2023-2025 | Adbry, Anzupgo |
| Sun Pharmaceutical Industries INC. | $73.71 | 2023-2024 | Ilumya |
| Boehringer Ingelheim Pharmaceuticals, INC. | $52.11 | 2022-2023 | Spevigo |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $44.07 | 2024 | Siliq, Targretin, Duobrii |
| Incyte Corporation | $39.64 | 2023-2024 | Opzelura |
| Pfizer INC. | $31.38 | 2024 | |
| Regeneron Healthcare Solutions, INC. | $29.29 | 2025 | Libtayo |
| Lilly USA, LLC | $23.50 | 2025 | Ebglyss |
| Organogenesis INC. | $21.38 | 2023 | Puraply |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Galderma Laboratories, L.P. | $19.15 | 2024 | |
| Celgene Corporation | $18.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Muneeb Ilyas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.